26th September 2022

Confidant Classes

Competitors' very first choice

Home | Edu NEWS | Remdesivir

Remdesivir

The US Food and Drug Administration has issued an emergency use authorization for Remdesivir, an investigational antiviral drug. With this authorization, physicians in the United States are now authorized to use the medication to treat patients with severe cases of COVID-19.

Remdesivir is not new, It was originally developed to treat Ebola and has also been laboratory tested against SARS and MERS, two other coronaviruses that infect humans in much the same way as the virus that causes COVID-19. It has never reached the approval stage for these uses, but in the past four months, scientists have desperately searched for options to help mitigate the coronavirus pandemic, and have turned to ancient drugs that could be reused.

Remdesivir has traveled an unprecedented path toward regulatory approval, making it one of the most promising treatments for COVID-19 to date. Remdesivir is not a vaccine and therefore cannot prevent infection; Instead, it works by attacking the virus once it has already spread within the body. Here is an overview of how the COVID-19 virus spreads in the human body and how the drug slows down this process.

  1. Virus enters a cell: Viruses cannot multiply without using the protein-producing machinery of a cell. Therefore, they must first enter a healthy cell. Coronaviruses, like the one caused by COVID-19, have a layer of sharp proteins that allow them to bind to cells.
  2. The virus releases the genetic code: the virus fuses with the cell and, once inside, releases a strand of RNA. Like a plan, RNA is a chain of genetic codes that has instructions for making exact copies of the virus.
  3. The genetic code is converted into proteins: tiny particles in the host cell, called ribosomes, are equipped to read genetic material. When the RNA from the virus crosses the ribosome, the ribosome produces viral proteins.
  4. Proteins make copies: Viral proteins are necessary to make copies of viral RNA, as well as other parts of the virus, such as the outer peaks and the membrane. As more and more protein and RNA chains are made, they proliferate, making exponentially more copies that fill the cell.
  5. The viral parts are assembled: the viral parts use mechanisms in the host cell to unite, forming a complete virus. Once fully assembled, the virus can leave the cell to find other healthy cells and begin the process again.
  6. Remdesivir blocks replication: Remdesivir mimics part of the viral RNA. During the copy process, it is inserted into the RNA strand. Once bound, the drug prevents further copies, leaving the RNA chain incomplete and unable to produce critical viral parts.
  7. The virus slows down: hindered by the drug, the entire replication process slows down. This means that fewer viruses are assembled. Defective viruses with partial RNA cannot replicate in other cells.

AILET 2023 Application Process Begins

National Law University-Delhi NLU-Delhi will hold the AILET 2023 exam on December 11, 11:00 a.m. to 5:00 p.m. m. to…
Read More

All India Bar Examination 17 Syllabus and other details

AIBE 17 exam: Nearly one lakh candidates will take the AIBE exam this year, which will be held at 150…
Read More

AIBE 17 will take place in 3 months: BCI informs the Supreme Court

Bar Council of India informed the Supreme Court that the syllabus for the upcoming All India Bar Examination 17 (AIBE17)…
Read More

Registration for CLAT 2023 will begin on August 8

CLAT 2023 will be held offline on December 18. Applicants can complete the online application form at consortiumofnlus.ac.in. CLAT 2023:…
Read More

AP LAWCET 2022 Results Declared

Confidant-Classes-Judiciary AP LAWCET 2022 Results: Candidates who sat for the AP Common Entrance Test (AP LAWCET 2022) will now be…
Read More

Law graduates not practising since more than 5 years, must retake AIBE: BCI tells the Supreme Court

The BCI has ruled that if a lawyer accepts a not related to legal or judicial matters, then that…
Read More

Careers after Law

Law has become the most common option in India at the moment. It has evolved and grown tremendously over time….
Read More

DU LLB Entrance Exam 2022 decoded

The University of Delhi will conduct the entrance exam of DU LLB 2O22 tentatively in next month. The university had…
Read More

UG-CLAT 2023 Exam Pattern

The UG-CLAT 2023 would focus on the assessment of the candidates’ comprehension and reasoning abilities and skills. In general, it…
Read More

70-Year-Old Fortunate to Complete LLM | University of Delhi Centenary Chance Initiative

Under the University of Delhi’s Centenary Chance initiative, a 70-year-old man is given the chance to complete his LLM after…
Read More

AatmNirbhar Bharat (4) AIBE (3) BCI (3) CACP (3) CBSE (3) CORONA VACCINE (3) Coronavirus (18) COVID 19 (14) COVID19 (3) CUET (4) DRDO (3) Facebook (5) farmers protest (3) Fiscal deficit (4) fiscal stimulus (4) FOREIGN EXCHANGE RESERVES (3) GDP (3) GI Tag (5) GI TAGS In iNDIA (3) GST (5) GST COMPENSATION (4) indian economy (20) INDO-CHINA BORDER DISPUTE (3) INDO-CHINA CONFLICT (6) INFLATION (3) INSTAGRAM (3) JIO (5) lockdown (6) MINIMUM SUPPORT PRICE (3) MONETARY POLICY COMMITTEE (4) MPC (5) MSP (3) NIRF (3) NOBEL PRIZE (3) nobel prize 2020 (5) PMI (3) RAFALE FIGHTER JET (3) RBI (12) RBI GOVERNOR (3) RELIANCE INDUSTRIES LIMITED (4) REPO Rate (4) RIL (8) supreme court of india (5) twitter (3) UNSC (3)

About Post Author

error

Enjoy this? Please spread the word :)